Wybrane rośliny lecznicze wspomagające odporność w walce z COVID-19: I. Charakterystyka wirusa SARS-CoV-2

Autor

  • Vladyslava Dubanska Uniwersytet Gdański
  • Agnieszka Kowalkowska Uniwersytet Gdański

DOI:

https://doi.org/10.26881/tutg.2022.3.10

Słowa kluczowe:

COVID-19, koronawirus, pandemia, SARS-CoV-2, ACE2, zespół ostrej niewydolności oddechowej

Downloads

Download data is not yet available.

Bibliografia

Barreiro, N.L., Ventura, C.I., Govezensky, T., Núñez, M., Bolcatto, P.G., Barrio, R.A., 2022. Strategies for COVID-19 vaccination under a shortage scenario: a geo-stochastic modelling approach. Scientific Reports, 12, 1603.

Ferrario, C.M., Ahmad, S., Groban, L., 2020. Mechanisms by which angiotensin-receptor blockers increase ACE2 levels. Nature Reviews Cardiology, 17, 378.

Ge, S., Wu, R., Zhou, T., Liu, X., Zhu, J., Zhang, X., 2022. Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus. AMB Express, 12(1), 1-12.

Gorbalenya, A., Baker, S., Baric, R., de Groot, R., Drosten, C., Gulyaeva, A., Haagmans, B., Lauber, C., Leontovich, A., Neuman, B., Penzar, D., Perlman, S., Poon, L., Samborskiy, D., Sidorov, I. A., Sola, I., Ziebuhr J., (Coronaviridae Study Group of the International Committee on Taxonomy of Viruses), 2020. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5, 536-544.

Hassan, S.S., Choudhury, P.P., Roy, B., 2020. Molecular phylogeny and missense mutations at envelope proteins across coronaviruses. Genomics, 112(6), 4993-5004.

Kaur, I., Behl, T., Aleya, L., Rahman, H., Kumar, A., Arora, S., Bulbul, I.J., 2021. Artificial intelligence as a fundamental tool in management of infectious diseases and its current implementation in COVID-19 pandemic. Environmental Factors and the Epidemics of COVID-19, 28, 40515-40532.

Letko, M., Marzi, A. Munster, V., 2020. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature Microbiology, 5, 562-569.

Li, F., 2016. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology, 3(1), 237-261.

Min, L., Sun, Q., 2021. Antibodies and Vaccines Target RBD of SARS-CoV-2. Frontiers in Molecular Biosciences, 8, 671633.

Otrisal, P., Bungau, C., Obsel, V., Melicharik, Z., Tont, G., 2021. Selected Respiratory Protective Devices: Respirators and Significance of Some Markings. Sustainability, 13, 4988.

Poles, J., Karhu, E., McGill, M., McDaniel, H.R., Lewis, J.E., 2021. The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review. Journal of clinical and translational research, 7(3), 333-376.

Rahman, M.H., Akter, R., Behl, T., Chowdhury, M.A., Mohammed, M., Bulbul, I.J., Elshenawy, S.E., Kamal, M.A., 2020. COVID-19 outbreak and emerging management through pharmaceutical therapeutic strategy. Current Pharmaceutical Design, 26, 5224- 5240.

Rothan, H.A., Byrareddy, S.N., 2020. The epidemiology and pathogenesis of coronavirus disease (COVID19) outbreak. Journal of Autoimmunity 109: 102433.

Tagde, P., Tagde, S., Tagde, P., Bhattacharya, T., Monzur, SM., Rahman, MH., Otrisal, P., Behl, T., Hassan, SS., Abdel-Daim, MM., Aleya, L., Bungau, S., 2021. Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2. Biomedicines, 9(9), 1266.

Wang, H.-Y., Li, X.-L., Yan, Z.-R., Sun, X.-P., Han, J., Zhang, B.-W., 2020. Potential neurological symptoms of COVID-19. Therapeutic Advances in Neurological Disorders, 13, 1-2.

Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., Li, H., 2020. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 10(5), 766-788.

Zhang, Y., Kutateladze, T.G., 2020. Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2. Nature Communications, 11, 2920.

Zhu, N., Zhang, D., Wang, W., Li, X., 2020. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727-733.

Źródła internetowe

The World Health Organization, 2020. Pneumonia of unknown cause – China. https://www.who.int/csr/don/05-january2020-pneumonia-of-unkown-cause-china/en/

The World Health Organization , https://www.who.int/director-general/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-oncovid-19---11-march-2020 [dostęp: 19.12.2022]

The World Health Organization , https://covid19.who.int/ [dostęp: 12.09.2022]

Encyklopedia PWN, https://encyklopedia.pwn.pl/szukaj/hipoksemia.html [dostęp: 05.09.2022]

COVID-19 Map Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html [dostęp: 19.09.2022]

SzczepieniaInfo, https://szczepienia.pzh.gov.pl/szczepionki/covid-19-2/ [dostęp: 07.09.2022]

The World Health Organization, https://www.who.int/activities/tracking-SARSCoV-2-variants [Aktualizacja z dn. 11.08.2022; dostęp: 07.09.2022]

NCBI, http://www.ncbi.nlm.nih.gov/nuccore/?term=txid2697049 [Opublikowany: 13.03.2020, dostęp: 07.09.2022]

Elektronogram SARS-CoV (transmisyjny mikroskop elektronowy, TEM). Zdjęcie autorstwa dr Freda Murphy'ego, z Biblioteki Obrazów Zdrowia Publicznego (PHIL) Centrum Kontroli i Zapobiegania Chorobom (CDC); numer identyfikacyjny 4814, https://phil.cdc.gov/Details.aspx?pid=15523 [dostęp: 19.12.2022]

Pobrania

Opublikowane

2022-12-19

Jak cytować

Dubanska, V., & Kowalkowska, A. (2022). Wybrane rośliny lecznicze wspomagające odporność w walce z COVID-19: I. Charakterystyka wirusa SARS-CoV-2. Tutoring Gedanensis, 7(3), 92–98. https://doi.org/10.26881/tutg.2022.3.10

Numer

Dział

Artykuły